Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection
- 1 January 1998
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 12 (1), 79-90
- https://doi.org/10.1096/fasebj.12.1.79
Abstract
Besides their role in hemostasis, platelets are involved in inflammatory and immunological processes, and we hypothezise that platelet activation may play an immunopathogenetic role in HIV-1 infection. Blood was drawn from 15 controls and 20 HIV-1-infected patients with normal platelet counts, classified into groups of non-AIDS and AIDS. Platelet activation was detected using flow cytometry with mAbs against the release markers P-selectin and CD63, mAb against GPIb, and the probe annexin V detecting surface exposure of aminophospholipids. The amount of microvesicles was measured using mAb against GPIIIa. Compared to controls, blood samples from HIV-1-infected patients showed significantly enhanced levels of microvesicles and activated platelets as detected by their exposure of P-selectin, CD63, and aminophospholipids, as well as reduction in GPIb expression. Increased expression of P-selectin and amounts of microvesicles were most pronounced in advanced clinical and immunological disease. When studying the effect of HIV-1 protease inhibitor therapy (indinavir) on platelet activation, we found that concomitant with a profound decrease in plasma viral load, there was a near normalization of several of the parameters reflecting enhanced platelet activation. Finally, we demonstrated that platelets may be an important source of the chemokine RANTES in HIV-1-infected patients. Although both unstimulated and SFLLRN-stimulated platelets from asymptomatic patients had enhanced release of RANTES, platelets from AIDS patients were characterized by markedly enhanced spontaneous, but decreased SFLLRN-stimulated release of this chemokine. Taken together, these results, which demonstrate for the first time increased platelet activation in HIV-1-infected patients with normal platelet counts, may represent a previously unrecognized immunopathogenic factor in HIV-1 infection.—Holme, P. A., Müller, F., Solum, N. O., Brosstad, F., Frøland, S. S., Aukrust, P Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection. FASEB J. 12, 79–90 (1998)Keywords
This publication has 53 references indexed in Scilit:
- Host factors and the pathogenesis of HIV-induced diseaseNature, 1996
- Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery diseaseEuropean Journal of Clinical Investigation, 1996
- A 24-week open-label Phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir)AIDS, 1996
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- Activation of Dual T Cell Signaling Pathways by the Chemokine RANTESScience, 1995
- Human Immunodeficiency Virus-Related Immune ThrombocytopeniaSeminars in Thrombosis and Hemostasis, 1995
- Proteinases and Cytokines in Neutrophil and Platelet Interactions In Vitro. Possible Relevance to the Adult Respiratory Distress SyndromeAnnals of the New York Academy of Sciences, 1994
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils.The Journal of Experimental Medicine, 1992
- Enhancement by IL-1β and IFN-γ of platelet activation: Adhesion to leukocytes via GMP-140 / padgem protein (CD62)Biochemical and Biophysical Research Communications, 1991